Anson Funds Management LP Clearside Biomedical, Inc. Call Options Transaction History
Anson Funds Management LP
- $420 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11.4MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$1.49 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.16 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$799,4210.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$423,0120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$419,8900.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $31.9M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...